More medication options and updated research about medication effectiveness has led to an update in AS treatment guidelines from the American College of Rheumatology.
Talz inhibits an immune system protein called IL-17 that can lead to inflammation.
This adds to what we know about environmental risk factors for autoimmune-related diseases.
Certain types of arthritis are prone to pain where tendons and ligaments meet bone, which is called enthesitis. Here’s how to deal with it.
A certain subset of people was more likely to achieve and stay in remission after starting the anti TNF biologic adalimumab.
Your SI joints connect your spine and pelvis — and they may be responsible for your lower back or buttock pain.
Knowing the factors that contribute to AS risk can help you watch out for them and possibly accelerate your diagnosis and treatment.
Doctors and patients need to be on the lookout for these additional symptoms.
Almost half of patients who start a TNF inhibitor biologic are not on the same treatment a few years later.
If you hear your doctor bring up the idea of using a ‘treat-to-target’ approach to manage your AxSpA, this is what it means.